PCC Rokita Balance Sheet Health
Financial Health criteria checks 6/6
PCC Rokita has a total shareholder equity of PLN1.3B and total debt of PLN636.4M, which brings its debt-to-equity ratio to 49.4%. Its total assets and total liabilities are PLN2.4B and PLN1.1B respectively. PCC Rokita's EBIT is PLN185.1M making its interest coverage ratio 6.6. It has cash and short-term investments of PLN198.6M.
Key information
49.4%
Debt to equity ratio
zł636.40m
Debt
| Interest coverage ratio | 6.6x |
| Cash | zł198.62m |
| Equity | zł1.29b |
| Total liabilities | zł1.12b |
| Total assets | zł2.41b |
Recent financial health updates
Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Aug 24
Is PCC Rokita (WSE:PCR) A Risky Investment?
Jan 18Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Jan 15
Recent updates
Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?
May 30Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Aug 24PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 29Is PCC Rokita (WSE:PCR) A Risky Investment?
Jan 18PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23
Apr 16Why We Like The Returns At PCC Rokita (WSE:PCR)
Mar 19What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?
Jan 25We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)
Sep 01Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching
Jun 14Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?
May 18Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes
Apr 13Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem
Mar 23PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Mar 09Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?
Feb 19What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?
Feb 04Is PCC Rokita (WSE:PCR) Using Too Much Debt?
Jan 15Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?
Dec 30Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years
Dec 17PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 03Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?
Nov 20Financial Position Analysis
Short Term Liabilities: PCR's short term assets (PLN713.6M) exceed its short term liabilities (PLN444.5M).
Long Term Liabilities: PCR's short term assets (PLN713.6M) exceed its long term liabilities (PLN677.7M).
Debt to Equity History and Analysis
Debt Level: PCR's net debt to equity ratio (34%) is considered satisfactory.
Reducing Debt: PCR's debt to equity ratio has reduced from 105.9% to 49.4% over the past 5 years.
Debt Coverage: PCR's debt is well covered by operating cash flow (52.6%).
Interest Coverage: PCR's interest payments on its debt are well covered by EBIT (6.6x coverage).